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We describe a novel stress-induced gene, noxin, and a knockout mouse line with an inactivated noxin gene.
The noxin gene does not have sequelogs in the genome and encodes a highly serine-rich protein with predicted
phosphorylation sites for ATM, Akt, and DNA-dependent protein kinase kinases; nuclear localization signals;
and a Zn finger domain. noxin mRNA and protein levels are under tight control by the cell cycle. noxin,
identified as a nitric oxide-inducible gene, is strongly induced by a wide range of stress signals: - and UV
irradiation, hydrogen peroxide, adriamycin, and cytokines. This induction is dependent on p53. Noxin accu-
mulates in the nucleus in response to stress and, when ectopically expressed, Noxin arrests the cell cycle at G1;
although it also induces p53, the cell cycle arrest function of Noxin is independent of p53 activity. noxin
knockout mice are viable and fertile; however, they have an enlarged heart, several altered hematopoietic
parameters, and a decreased number of spermatids. Importantly, loss or downregulation of Noxin leads to
increased cell death. Our results suggest that Noxin may be a component of the cell defense system: it is
activated by various stress stimuli, helps cells to withdraw from cycling, and opposes apoptosis.
Cells respond to oxidative and genotoxic stress by withdraw-
ing from the cell cycle, repairing the damaged regions of DNA,
repairing or destroying affected proteins, altering growth char-
acteristics, and seeking to inactivate the stressor. Alternatively,
if the stress-induced damage is too extensive, cells may be
eliminated by apoptosis. Various stressors (e.g., ionizing radi-
ation, UV radiation, reactive oxygen and nitrogen species, and
alkylating chemicals) act differently and cause distinct types of
damage to the cell; at the same time, these dissimilar insults
activate shared sets of molecules and pathways aimed at min-
imizing the damage and repairing the affected cell components
(1, 11, 12, 16). The cellular defense mechanisms include im-
mediate responses (e.g., posttranslational modifications of the
tumor suppressor protein p53, leading to its accumulation in
the cells), as well as more extended responses (e.g., transcrip-
tional activation of sets of crucial genes whose products help
the cells to complete the repair process or to communicate the
stress and repair signals to the surrounding cells). Together,
this coordinated set of protein modification and gene activa-
tion events helps ensure that the damage to cells is minimized
and that cells restore their prestress status (e.g., return to
cycling).
Nitric oxide (NO) is a versatile signaling molecule that is
involved in both physiologic (e.g., vasorelaxation and neuro-
transmission) and pathological (e.g., inflammation and cell
death) processes in the organism (3, 15, 19). When produced at
high levels (e.g., by the high-output inducible NOS isoform), it
can induce cell damage and subsequent apoptosis (4, 17). At
lower levels, NO can act as an antiproliferative agent in vitro
and in vivo, contributing to cell cycle arrest during cell differ-
entiation or inflammation. When acting upon the cell cycle
machinery, NO affects multiple pathways and can contribute to
cell cycle arrest through several independent mechanisms (5,
8–10, 19, 20, 22). Several major regulators of the cell cycle and
stress response, e.g., cyclin-dependent kinase 2 (cdk2), cdk
inhibitor p21/WAF, cyclin D1, PCNA, ribonucleotide reduc-
tase, mdm2, p53, and ataxia telangectasia mutated kinase
(ATM) are involved in the cellular response to NO (2, 14, 18,
24, 25). Given the extent of NO involvement in cell physiology,
it is likely that specific additional components mediate the
response to NO in particular contexts. At the same time, it is
conceivable that responses to NO engage mechanisms that are
employed by cells in responding to other stressful stimuli.
While searching for NO-inducible genes, we identified a new
gene that was strongly induced by different NO donors. We
found that this gene, noxin, was also strongly induced by a
range of other stress stimuli. Here, we describe noxin as a novel
component of the stress response system and describe a line of
knockout mice in which the noxin gene has been inactivated.
We show that Noxin expression is regulated throughout the
cell cycle, that its expression is strongly induced by stress, that
it can effectively induce arrest of cells in G1 phase, and that its
loss leads to increased apoptosis. Our results suggest that noxin
may be an important component of the repair machinery of the
stressed cell.
MATERIALS AND METHODS
Cell culture and reagents. NIH 3T3 fibroblasts were maintained at 37°C in an
atmosphere of 5% CO2 in Dulbecco modified Eagle’s medium (DMEM) with
10% calf serum. Mouse embryonic fibroblasts (MEFs) were isolated from em-
bryonic day 13 to 14 mouse embryos, treated with trypsin, and cultured in
DMEM with 10% fetal calf serum. S-Nitroso-N-acetyl-D,L-penicillamine
(SNAP), 1-hydroxy-2-oxo-3-(N-ethyl-2-aminoethyl)-3-ethyl-1-triazene (NOC12),
and DETA NONOate (NOC18) were purchased from Calbiochem and used at
a concentration of 250 M. Adriamycin (Sigma) and hydrogen peroxide (Sigma)
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were added to the cultures at concentrations of 0.1 g/ml and 5 M, respectively.
-irradiation was performed at 10 Gy to induce noxin mRNA using a -irradiator
(Atomic Energy of Canada; Mark I cesium-137 irradiator). UV irradiation (120
J/m2) was performed by placing cell culture plates in the transilluminator (Fo-
todyne, Inc.). The following cytokines were used: tumor necrosis factor alpha
(TNF-) (10 ng/ml; R&D Systems), gamma interferon (IFN-) (200 U/ml; Cal-
biochem), and interleukin-1 (IL-1) (200 pg/ml; R&D Systems).
Cell cycle synchronization. NIH 3T3 cells and MEFs were cultured for 24 h in
DMEM containing 0.5% and 0.1% calf serum, respectively, to synchronize them
in G0 phase. The cells were stimulated to reenter the cell cycle by replacing the
medium with DMEM (10% calf serum). For synchronization in the S and G2/M
phases, cells were treated for 20 h with aphidicolin (6 M) or nocodazole (100
ng/ml), respectively.
Plasmid construction. cDNA encoding the entire Noxin polypeptide was ex-
cised from IMAGE clone AI157360 (Research Genetics) with XhoI and sub-
cloned into pcDNA3 (Invitrogen). The 5-end XhoI-HindIII noxin cDNA frag-
ment was amplified by PCR using primers with a two-FLAG-tag sequence and
used to replace the original Noxin sequences to generate the pFLAG-noxin
expression plasmid. Plasmids expressing p53, p53dn (a dominant-negative form
of p53), and p21/WAF were gifts from S. Lowe (Cold Spring Harbor Labora-
tory). pEGFP-N1, pCFP-nuc, and pYFP-actin were purchased from Clontech.
noxin shRNA constructs. Plasmids expressing six different noxin short hairpin
RNAs (shRNAs) (HPA to HPF) under the control of the human U6 promoter
were generated as described previously (21). U6 promoter cassette DNA was
amplified using a 5 primer corresponding to the SP6 site at the 5 end of the U6
promoter cassette and a long 3 primer complementary to the 3 end of the
promoter and containing sequences for the noxin shRNA and a polymerase III
termination site. The PCR fragments obtained were subcloned into pENTR-
TOPO-D vector (Invitrogen) and then transferred into pMSCV-puro vector by
a clonase (Invitrogen) reaction.
Total-RNA extraction and poly(A) RNA isolation. Cells cultured in 10-cm
plates were lysed with 2 ml of TRIzol (Invitrogen), and total RNA was isolated
according to the manufacturer’s protocol and then resuspended in 10 mM Tris-
HCl, 1 mM EDTA, pH 7.4, buffer at a final concentration of 2 g/l. poly(A)
RNA was isolated using the FastTrack 2.0 kit (Invitrogen) according to the
manufacturer’s instructions.
cDNA microarray analysis. Total RNA was isolated from untreated cells and
cells treated with NO donors: SNAP, NOC12, and NOC18. NO-induced gene
expression changes were determined by cDNA microarray analysis as described
previously (13). Briefly, poly(A) RNA samples were labeled with Cy5 or Cy3
fluorescent dye and hybridized to custom printed slide arrays produced by the
Cold Spring Harbor Laboratory Genome Center. After being washed, the mi-
croarray slides were scanned using a GenePix scanner and software (version 3.0;
Axon Instruments, Inc.).
Real-time quantitative reverse transcription-PCR (Q-PCR). Total RNA (2
g) was converted into cDNA by Taqman Multiscribe reverse transcriptase (125
U; Applied Biosystems) using random hexamer primers. The cDNA was diluted,
mixed with 2 SYBR Green PCR Master Mix (Applied Biosystems) and 0.3 M
both forward and reverse primers, and amplified using the ABI PRISM 7700
Sequence Detection System (Applied Biosystems). The following primers (Sigma
Genosys) for noxin and -actin were designed using Primer Express software
(Applied Biosystems), assuming a melting temperature of 58 to 60°C and an
amplicon size of 70 to 150 bp: 5-TTTCTACCGGATACTTGCTCATCA-3
(noxin-FW), 5-GTTGCAAGACCCCACTAGTCCT-3 (noxin-RV), 5-CGTG
AAAAGATGACCCAGATCA-3 (-actin-FW), and 5-CACAGCCTGGATG
GCTACGTA-3 (-actin-RV).
The PCR conditions for the thermal cycler were as follows: denaturation (1
cycle at 95°C for 10 min) and amplification (40 cycles at 95°C for 15 s and 60°C
for 1 min). During amplification, the fluorescence of each sample in the plate was
detected in real time and an amplification curve was drawn with Sequence
Detection System Software (Applied Biosystems) to get the threshold cycle, the
cycle number at which the curve started to rise over the background noise. The
data from noxin amplifications were normalized using the threshold cycle value
from the -actin set for each sample, and the difference between the amounts of
noxin RNA in untreated and in stress-exposed cells was calculated.
Northern blot analysis. Total RNA (10 g) was separated by denaturing
formaldehyde-agarose gel electrophoresis and transferred onto a nylon mem-
brane (Hybond-N; Amersham). The membrane was prehybridized with hybrid-
ization buffer (0.05 M sodium phosphate buffer, 5 SSC [1 SSC is 0.15 M NaCl
plus 0.015 M sodium citrate], 4Denhardt’s solution, 1% sodium dodecyl sulfate
[SDS], 50% formamide, 0.1 mg/ml salmon sperm DNA, and 0.2 mg/ml yeast
tRNA) for 6 h at 42°C and hybridized with the same buffer containing 100,000
cpm/ml [-32P]dCTP-labeled noxin cDNA probe amplified by PCR from
pFLAG-noxin. Following hybridization for 20 h at 42°C, the membrane was
washed twice with 2 SSC for 5 min each time at room temperature, twice with
0.2 SSC for 5 min each time at 65°C, and twice with 1 SSC with 3% glycerol
for 5 min each time at room temperature. The membrane was exposed for 3 days
at 70°C to X-OMAT X-ray film (Kodak).
5-RACE. 5 rapid amplification of cDNA ends (RACE) was performed using
the FirstChoice RLM-RACE kit (Ambion) according to the manufacturer’s
instructions. Poly(A) RNA isolated from adult mouse testes was reverse tran-
scribed into cDNA. A specially designed adaptor sequence provided in the
RLM-RACE kit was ligated to the ends of the cDNA, and the adaptor primer
served as the forward primer. An antisense gene-specific primer (5-GAAGCA
CCTTTGACATGATGGA-3) derived from nucleotides 270 to 291 in the noxin
cDNA and an antisense gene-specific primer (5-TGGCCCTTCTTGGCATAA
TG-3) derived from nucleotides 125 to 144 served as the outer and nested
primers, respectively. The PCR products were cloned into pCRII-TOPO vector
(Invitrogen) and sequenced.
Western blot analysis. Cells or tissues were homogenized in lysis buffer (10
mM Tris-HCl, pH 7.5, 1 mM EDTA, 400 mM NaCl, 0.5% NP-40, 5 mM NaF, 0.5
mM sodium orthovanadate, 10% glycerol, 1 mM dithiothreitol, 1 mM phenyl-
methylsulfonyl fluoride, 1 g/ml aprotinin, 1 g/ml leupeptin, and 1 g/ml
pepstatin) for 20 min on ice. Following centrifugation, the soluble fraction was
collected and the protein concentration was determined using a bicinchoninic
acid assay kit (Pierce). Fifty micrograms of total protein was separated on an 8%
SDS-polyacrylamide gel electrophoresis gel and transferred to an Immobilon-P
membrane (Millipore Corporation) by semidry blotting. The membranes were
incubated with anti-FLAG antibody (1:1,000; Sigma) or anti-Noxin antibody
(1:1,000), followed by anti-mouse immunoglobulin G (IgG) or anti-rabbit IgG
antibody conjugated to horseradish peroxidase (HRP) (1:10,000; Amersham).
The HRP signal was detected using a chemiluminescence detection kit (Super-
Signal Femto Dura Extended Duration Substrate; Pierce) and Hyperfim X-ray
film (Amersham Biosciences).
Immunocytochemistry. Cells grown on coverslips coated with collagen and
poly-L-lysine were fixed with 4% methanol-free formaldehyde in phosphate-
buffered saline (PBS) for 20 min on ice. After permeabilization with 0.1% Triton
X-100 in PBS for 10 min on ice, the cells were incubated with primary and
secondary antibodies in PBS (containing 0.05% Tween 20 and 1% bovine serum
albumin [BSA]) each for 1 h at room temperature. The primary antibodies used
in these experiments were anti-FLAG (1:500; Sigma), anti-p53 (1:1,000; Novo-
castra), and fluorescein isothiocyanate (FITC)-conjugated anti-8-bromode-
oxyuridine (BrdU) antibody (1:500; Pharmingen). The secondary antibodies
were ALEXA Fluor 488-conjugated goat anti-mouse IgG (1:500; Molecular
Probes) and ALEXA Fluor 546-conjugated goat anti-rabbit IgG (1:500; Molec-
ular Probes). Cell nuclei were counterstained with Hoechst 33342 (Molecular
Probes), and the coverslips were mounted with Gel/Mount medium (Biomega).
Fluorescence signals were analyzed under a fluorescence microscope (Zeiss
Axiophot) equipped with Plan-Neofluar objectives (40 to 100) and a charge-
coupled device camera. Data were analyzed with Photoshop software (version 6;
Adobe).
In situ hybridization. Adult mouse (C57BL/6) tissues were directly frozen in
OCT compound (Tissue-Tek), sectioned by cryostat (10-m thickness), and
mounted on glass slides (ProbeOn Plus; Fisher). The noxin cDNA PCR fragment
was subcloned into pCRII-TOPO. Digoxigenin (DIG)-labeled noxin RNA
probes were transcribed from SacI-linearized constructs in vitro using T7 RNA
polymerase (DIG RNA Labeling kit; Boehringer Mannheim) according to the
manufacturer’s instructions. Hybridized RNA was detected using alkaline
phosphatase-conjugated anti-DIG according to the procedure described pre-
viously (6).
Flow cytometry analysis and cell cycle determination. BrdU-labeled (10 M)
cells collected from plates by trypsin digestion were suspended in saline and fixed
with 70% ethanol. After being washed with PBS with 0.05% BSA, 1  106 cells
were incubated with FITC-conjugated anti-BrdU antibody (Pharmingen; 1:500)
for 1 h, suspended in PBS-BSA with 5 g/ml propidium iodide (PI) and 20 g/ml
RNase A, and incubated further for 30 min at room temperature. For bivariate
cell cycle analysis, cells were analyzed using an LSRII flow cytometer (Perkin-
Elmer). For the detection of p53 by cytometric analysis, pFLAG-noxin- or
pEGFP-transfected cells were fixed with 4% paraformaldehyde, permeabilized
with saponin, and stained with primary antibodies (CM5 anti-p53 polyclonal
antibody and M1 anti-FLAG monoclonal antibody, both from Sigma) and then
with secondary antibodies (phycoerythrin [PE]-conjugated goat anti-rabbit IgG
and FITC-labeled goat anti-mouse IgG). Cells were analyzed for PE, FITC, and
green fluorescent protein (GFP) fluorescence by flow cytometry.
noxin knockout mice. The bacterial artificial chromosome (BAC) containing
the entire noxin gene was obtained by screening the BAC library with the noxin
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cDNA clone. The resulting BAC clone was digested with EcoRI and HindIII to
isolate the left and right arms of the targeting construct, respectively. After
digestion and gel separation, 2-kb and 3-kb fragments were subcloned to flank
both sides of the neomycin resistance gene in the pPNT vector, generating the
noxin targeting vector pPNT-noxin. Cultured embryonic stem cells were trans-
fected with pPNT-noxin, and neomycin-resistant clones were selected for by
treatment with G418. Four hundred neomycin-resistant clones were screened by
nested PCR and further by genomic Southern blots. Two of the seven positive
embryonic stem cell clones were injected into mouse blastocysts, and mice were
generated using standard techniques. The mice were genotyped by PCR using
primer sets specific for the wild-type and knockout alleles.
Detection of endogenous Noxin protein. Anti-Noxin antiserum was raised by
immunizing a rabbit with a peptide sequence located at the C-terminal region
(870 to 886) of Noxin (RKCLDLHYSPDPKELPR). For immunohistochemistry,
mice were perfused transcardially with PBS and then with 4% paraformaldehyde
in PBS at 4°C. Dissected testes were postfixed for 4 h and cryoprotected in 30%
sucrose overnight at 4°C. Sections were cut on a cryostat (10-m thickness) and
collected on coated slides (ProbeOn Plus; Fisher). The slides were gradually
dehydrated, air dried, and stored at 20°C. Following rehydration, the slides
underwent an antigen retrieval step: 10 min of incubation at 95 to 100°C in 0.01
M sodium citrate (pH 6.0), cooling to room temperature, and rinsing with
distilled water. The slides were then incubated in 0.3% hydrogen peroxide to
inactivate endogenous peroxidases, washed in PBS containing 0.1% Triton X-100
(PBS-T), and blocked at room temperature for 1 h in 3% normal goat serum in
PBS-T. The slides were incubated overnight at 4°C with primary antibody (anti-
Noxin antibody [1:500]) diluted in PBS-T with 1% goat serum. After being
washed with PBS-T, the slides were incubated with a biotinylated goat anti-rabbit
secondary antibody (1:200; Vector Laboratories) for 2 h, followed by further
washing and incubation in HRP-conjugated avidin-biotin complex (Vector ABC
Elite) for 1.5 h before being stained with 3,3-diaminobenzidine and hydrogen
peroxide. All slides were counterstained with hematoxylin, and coverslips were
mounted with Permount (Fisher).
Analysis of testis parameters. Immediately after euthanization of adult mice
(n	 6 for wild-type and n	 7 for noxin/ mice), the testes were removed, fixed
with 2% glutaraldehyde, and embedded in Epon. Semithin sections (1 m) were
cut on a microtome (Reichert Ultrcut E; Leica, Nussloch, Germany) and stained
with toluidine blue-pyronine. For analyzing potential differences in spermato-
genesis between wild-type and knockout mice, cross sections of seminiferous
tubules displaying the same stages of spermatogenesis were analyzed. We se-
lected intact tubular cross sections of stage VI of spermatogenesis (n 	 93 for
wild-type and n 	 77 for noxin/ mice) and measured the tubular diameter,
which correlates with strong disturbances of spermatogenesis. We also counted
the spermatocytes I and round spermatids visible in these tubules. The data are
presented as means 
 standard errors of the mean of all seminiferous tubules
analyzed. Statistical analysis was performed using SPSS Base 12.0 (SPSS Soft-
ware, Munich, Germany). Differences among experimental groups were analyzed
with Mann-Whitney test as installed in SPSS Base, with a P value of 0.05
considered significant and a P value of 0.01 highly significant.
Cell cycle analysis of MEFs. MEFs isolated from wild-type or noxin/ mice
were incubated in low-serum medium (0.5% fetal bovine serum) for 24 h to stop
the cell cycle. The medium was then replaced with 10% fetal bovine serum, and
SNAP and BrdU were added to the medium. At the end of the incubation,
BrdU-labeled cells were stained with FITC-conjugated anti-BrdU antibody and
analyzed by flow cytometry.
Detection of apoptotic cells. To detect apoptosis, MEFs isolated from wild-
type or noxin/ mice were grown on coverslips coated with collagen and poly-
L-lysine, washed with PBS, and processed for the terminal deoxynucleotidyl-
transferase-mediated dUTP–fluorescein nick end labeling (TUNEL) assay
according to instructions in the ApoAlert DNA Fragmentation Assay Kit (BD
Biosciences). TUNEL-positive cells were quantified by microscopy. Wild-type
and noxin/ MEFs were also grown in culture, washed with PBS, and stained
with a FITC-conjugated annexin V antibody (Molecular Probes) and PI accord-
ing to the manufacturer’s instructions. The percentage of annexin V-positive cells
was determined by flow cytometry.
Nucleotide sequence accession number. The noxin gene sequence was submit-
ted to GenBank under accession no. DQ400346.
RESULTS
Molecular cloning of noxin. We recently determined the
temporal order of gene activation induced by NO in mamma-
lian cells (13). Among the genes whose expression was affected
most strongly by three unrelated chemical donors of NO
(SNAP, NOC12, and NOC18) (Fig. 1A) was a previously
uncharacterized mouse expressed sequence tag (EST)
(IMAGE524571 in the I.M.A.G.E. consortium database). This
EST sequence was used for further searches, and a larger
cDNA clone (GeneID, 74041), which contained the entire
coding region of the gene, was identified in the NCBI database.
5-RACE analysis confirmed that this 3,384-bp-long cDNA
contained the 5 end of the mRNA (with a stop codon preced-
ing the open reading frame) and coded for a protein of 898
amino acids (Fig. 1B), with a predicted molecular mass of 100
kDa and an isoelectric point of 7.23. We raised a polyclonal
antibody against a peptide from a C-terminal region of the
deduced protein and demonstrated that upon transfection into
cultured cells, the cloned cDNA generated a protein with elec-
trophoretic mobility corresponding to that of the endogenous
protein (Fig. 2D, f; also see Fig. 4C and 5C and D). We named
this gene noxin (for nitric oxide-inducible). The noxin gene is
located on mouse chromosome 7 and is conserved (70% sim-
ilarity at the DNA level) in the rat and human genomes (lo-
cated on rat chromosome 1 and human chromosome 11) (Fig.
1B). The gene seems to be unique in the rodent and human
genomes and does not have obvious closely related sequelogs.
An unusual feature of the deduced Noxin protein sequence is
that it is very rich in serines (134 serine residues), suggesting
phosphorylation of these residues as a possible modification.
Indeed, in the extracts of both the animal tissue and cultured
NIH 3T3 cells after transfection with the noxin cDNA, two
distinct bands were apparent on the SDS-polyacrylamide gel
(Fig. 2D, f; also see Fig. 4C and 5C and D), and the intensity
of the upper band was markedly reduced upon phosphatase
treatment (data not shown).
A search for possible phosphorylation sites in Noxin pro-
duced consensus sites for modifications by DNA-dependent
protein kinase (DNA-PK), ATM, and Akt (Fig. 1C), suggest-
ing that Noxin may be modified by these kinases in response to
stress. Noxin also carries two predicted nuclear localization
domains near the N and C termini and a part of the C3HC4-
type zinc finger domain in the N-terminal region.
Expression of Noxin. Northern blot analysis of RNAs from
different mouse tissues showed that Noxin is strongly expressed
in the testis and also in the spleen and heart (Fig. 2A). Q-PCR
confirmed these data and showed that Noxin expression can
also be detected in the bone marrow, brain, lung, liver, and
kidney (Fig. 2B).
Strong expression of Noxin in the testis was confirmed and
further analyzed by in situ hybridization, immunocytochemis-
try, and Western blot analysis (Fig. 2). Differentiating male
germ cells in the seminiferous epithelium of the testis are
spatially and temporally arranged in a distinct pattern that
enables their identification: the spermatogonia are localized
along the basement membrane at the periphery of the tubules,
whereas the primary spermatocytes are localized in the middle
layers of the tubules and the spermatids are found close to the
lumen (Fig. 2C); furthermore, the distinct morphology of sper-
matocytes allows their discrimination among the other cell
types in the tubules.
Hybridization with the antisense strand of noxin cDNA
showed that the signal is largely limited to primary spermato-
cytes, with the sense probe producing no signal (Fig. 2C). This
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FIG. 1. Cloning of the noxin gene. (A) noxin is induced by NO donors. Images from microarray analysis showing up-regulation of two distinct
genes in a section of the array. NIH 3T3 cells were treated with three different donors of NO (SNAP, NOC12, and NOC18). cDNA probes
prepared using RNAs from NO donor-treated and untreated cells were labeled with fluorescent dyes (Cy3 and Cy5, with color reversal) and
hybridized to custom cDNA microarray slides. One EST gene, IMAGE524571 (noxin), was strongly induced by all three donors; mdm2 is shown
as another example of a strongly induced gene. (B) Deduced amino acid sequence of Noxin. Cloned cDNA of 3,384 bp was sequenced, and the
898-amino-acid-coding region was deduced. Noxin contains a zinc-finger-like domain (light blue) in the N-terminal region; DNA-PK, ATM, and
Akt phosphorylation consensus sequences (pink); and two potential nuclear localization signals (red italics). The light-purple letters represent an
overlap of the ATM and Akt consensus sequences. Corresponding human and rat partial protein sequences were generated using EST and genome
databases. The asterisks denote identical amino acids. (C) Schematic arrangement of protein motifs (represented by the same colors as in panel
B) in the Noxin polypeptide.
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was further confirmed by immunocytochemistry, using a poly-
clonal antibody to Noxin (Fig. 2D). Noxin protein is highly
expressed in the primary spermatocytes and, to a lesser extent,
in the round spermatids (Fig. 2D, a). This staining is highly
specific, as the signal is absent in each of the following: in testes
from noxin knockout animals (Fig. 2D, c); in the presence of
the peptide used to raise the antibody, added as a competitor
(Fig. 2D, d); or in the absence of the primary antibody (Fig.
2D, e). Antibody staining, particularly when visualized using
Nomarski imaging (Fig. 2D, b), demonstrates that in primary
FIG. 2. Distribution of noxin mRNA and protein in adult mouse tissues. (A and B) Total RNA was extracted from different adult mouse tissues
and analyzed for noxin mRNA by Northern hybridization (A) and Q-PCR (B). The Q-PCR data represent relative amounts of noxin mRNA
compared to its levels in the skeletal muscle. Testis, bone marrow, spleen, and heart are enriched in noxin mRNA. (C) The expression pattern in
adult mouse testes visualized by in situ hybridization using a DIG-labeled antisense noxin RNA probe (top) and a sense RNA probe (bottom).
noxin mRNA is mainly expressed in primary spermatocytes. Scale bars, 25 m. (D) Anti-Noxin antibody reveals immunoreactive structures in or
adjacent to the cell nuclei in primary spermatocytes (a). Nomarski images confirm that Noxin protein is localized predominantly in the primary
spermatocytes (b). Testes from a noxin/ mouse did not show Noxin signals (c). The staining was eliminated by the addition of the antigen peptide
to the primary antibody solution (d) or after staining without the primary antibody (e). Western blot analysis showed that Noxin protein is
expressed in the testes of the noxin/ but not of noxin/ animals; its expression is reduced in the noxin/ heterozygotes (f). In images a and
b, arrows and labels identify specific tissues and germ cell types: BM, basement membrane; Sg, spermatogonia; Sp, primary spermatocyte; Sd,
spermatid. WT, wild type. Scale bar, 25 m.
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spermatocytes, Noxin is localized to the periphery of the nu-
cleus, in a structure which may correspond to the centrosome,
the Golgi body, or the XY body of these cells. The expression
of Noxin in the testis was also confirmed by Western blots,
which showed Noxin expression in the testes from wild-type
mice, absence of the protein in the knockouts, and an inter-
mediate level of expression in heterozygous animals (Fig. D, f).
To further determine the subcellular localization of Noxin,
we transfected NIH 3T3 cells with a plasmid encoding Noxin
tagged with the FLAG epitope at its N terminus (pFLAG-
noxin). A majority of the transfected cells showed nuclear
localization of Noxin, compatible with the presence of two
predicted nuclear localization signals in the Noxin protein (Fig.
3A and B); at the same time, in a number of cells, Noxin was
present in the cytoplasm (Fig. 3A). The distributions of the
protein were identical whether revealed by the polyclonal an-
tibody to Noxin or by the antibody to the FLAG epitope (Fig.
3C to E). When in the nucleus, Noxin can be seen in sub-
nuclear particles in the euchromatic regions; these Noxin-con-
taining particles did not colocalize with several subnuclear
structures revealed with antibodies to PML (a component of
PML bodies), SF2 (a component of spliceosomes), or phos-
pho-H2AX (a DNA repair-related protein) (data not shown).
When the distribution of the endogenous Noxin protein was
examined in NIH 3T3 cells, it was found to be localized both to
the cytoplasm (predominantly) and to the nucleus (Fig. 3F and
G). However, the protein accumulated in the nucleus when
cells were exposed to the NO donor SNAP. Together, our
results show that Noxin is expressed in primary spermatocytes
of the testis, where it is localized to discrete subcellular struc-
tures, and that it is also expressed in the fibroblasts and accu-
mulates in the nucleus in response to NO.
noxin expression is induced in response to stress in a p53-
dependent manner. noxin was identified as an NO-inducible
gene, and we determined the time course of its induction by
the NO donor SNAP. noxin mRNA levels started to increase
2 h after the addition of SNAP and reached maximal levels 8 h
after the addition (Fig. 4A). The pattern of noxin induction by
SNAP was similar to that of a p53-dependent gene, mdm2,
suggesting that noxin expression may be controlled by p53
(note that we have previously shown that in the absence of the
p53 gene, the induction of noxin by SNAP is reduced [13]).
FIG. 3. Subcellular distribution of Noxin. (A and B) NIH 3T3 cells were transfected with pFLAG-noxin. The cells were stained with anti-FLAG
antibody (red) and Hoechst 33342 to visualize the nuclei (blue). The FLAG-Noxin protein is present in the cytoplasm (arrow) or in the nucleus
(arrowhead) of the transfected cells (A). It is often seen in small subnuclear particles (B). (C to E) Staining of pFLAG-noxin-transfected cells with
anti-Noxin antibody (C), anti-FLAG antibody (D), or Hoechst 33342 (E). (F and G) Endogenous Noxin, visualized with an antibody raised against
a C-terminal region peptide, is mainly localized in the cytoplasm. Exposure to SNAP results in a predominantly nuclear localization of the protein
(note that the quality of the endogenous Noxin signal did not allow us to visualize its precise subnuclear distribution). Scale bars, 5 m.
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We next examined whether induction of noxin is specific to
NO or whether noxin expression can also be induced by other
known stress stimuli. We exposed NIH 3T3 cells to -irradia-
tion, UV irradiation, the chemotherapeutic agent adriamycin,
and hydrogen peroxide; we also used a mixture of cytokines
(TNF-, IFN-, and IL-1), which is known to be a potent
inducer of reactive oxygen and nitrogen species. Each of these
treatments resulted in a strong induction of noxin mRNA (e.g.,
21-fold for the UV irradiation) (Fig. 4B), demonstrating that
the noxin gene can respond to a wide range of dissimilar stimuli
by transcriptional activation, thus characterizing noxin as a
general stress-responsive gene.
In parallel to the noxin mRNA accumulation in response to
the stress stimuli, Noxin protein levels were also increased by
each of the tested stimuli (Fig. 4C). In unstimulated cells,
endogenous Noxin protein is revealed on the Western blot as
a major band migrating at 116 kDa and a minor band at 125
kDa. All of the examined stimuli increased the Noxin protein
levels, and some (e.g., SNAP, UV irradiation, adriamycin, and
H2O2) specifically increased the levels of the 125-kDa polypep-
tide; furthermore, in the SNAP-, cytokine-, -irradiation, and
adriamycin-treated cells, an additional band of 129 kDa was
evident. Together, these results demonstrate that noxin mRNA
and protein expression is strongly induced by each of the tested
stress stimuli and that a specific set of polypeptides (presum-
ably reflecting posttranslational modifications of the serine-
rich Noxin protein) is induced in response to each stimulus.
We next examined the contribution of p53 to noxin induction
by comparing the effect of the stress treatments applied to the
NIH 3T3 cells (see above) on noxin mRNA expression in
MEFs from wild-type and p53/ animals. Similar to the NIH
3T3 cells, each of these treatments increased the levels of noxin
expression in MEFs, and in each case, this induction was ab-
rogated by the lack of p53 (Fig. 4D). This confirms the stress-
responsive nature of the noxin gene and demonstrates that
induction of noxin in response to stress is dependent on p53.
noxin expression is regulated by the cell cycle. We next
examined the possibility that noxin expression is related to cell
cycle progression. When NIH 3T3 cells were arrested in G0
phase by serum withdrawal, noxin mRNA expression was
strongly reduced compared to that in asynchronously dividing
cells (Fig. 5A). When the cells were released from cell cycle
arrest by the addition of serum, noxin mRNA was strongly
induced (up to 15-fold) as the cells passed through S and G2
phases (the status of the cell cycle was determined by flow
cytometry) (Fig. 5B). The cell cycle-dependent expression was
also evident for the Noxin protein: its levels were lower in the
arrested cells than in the asynchronous culture and strongly
increased after the addition of serum and progression through
the cell cycle (Fig. 5C). The Noxin levels were highest in cells
in G2/M phase; they were also induced by the cell cycle inhib-
FIG. 4. noxin mRNA is induced by NO and other stress stimuli in
a p53-dependent manner. (A) Northern blot showing the kinetics of
noxin and mdm2 mRNA induction by SNAP. Results for -actin are
shown as a control. (B) noxin mRNA is induced by a variety of stress
stimuli. noxin mRNA was quantitated by Q-PCR in samples from NIH
3T3 cells treated for 16 h with SNAP, a cocktail of cytokines (TNF-,
IFN-, and IL-1), -irradiation (-IR), UV irradiation (UV-IR),
adriamycin (ADR), or hydrogen peroxide (H2O2). (C) Noxin protein is
induced by stress stimuli. NIH 3T3 cells treated with stress stimuli
(arranged in the same order as in panel B) were analyzed for the Noxin
protein by Western blotting using anti-Noxin antibody. Noxin appears
in three separate bands of 116, 125, and 129 kDa. (D) noxin RNA
induction by stress stimuli is dependent on p53. p53/ and p53/
MEFs were exposed to stress stimuli (the lanes are arranged in the
same order as in panel B) and analyzed for noxin mRNA expression.
The error bars indicate standard errors of the mean.
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itors nocodazole and aphidicolin (note that the levels of the
minor 125-kDa and 129-kDa bands were selectively increased
in response to serum or the inhibitors) (Fig. 5C). Noxin ex-
pression was higher in cells treated with nocodazole (which
arrests cells in G2/M phase) than in cells exposed to aphidi-
ciolin or serum withdrawal (which induce S- and G1-phase
arrest, respectively).
High levels of noxin mRNA and protein expression in se-
rum- and nocodazole-treated cells in G2/M phase raise the
possibility that the stress-induced expression of noxin (Fig. 4)
merely reflects accumulation of cells in the G2/M phase. We
examined the cell cycle phase distribution of NIH 3T3 cells
exposed to each of the stress stimuli used for the experiments
in Fig. 4 and found (i) that each of these stimuli induced a
specific pattern of cell cycle phase distribution and (ii) that
there was no correlation between the level of noxin mRNA
induction in response to a certain stimulus and the proportion
of cells accumulating in G2/M phase in response to this stim-
ulus (for instance, the fraction of G2/M cells after exposure to
-irradiation was 2.75- and 1.75-fold higher than after expo-
sure to cytokines and H2O2, respectively, whereas mRNA lev-
els were 1.5- and 2.5-fold lower; furthermore, the proportion of
G2/M cells following H2O2 exposure was similar to that of
unstimulated cells, yet the mRNA level was 13-fold higher)
(Fig. 5E). Together, our results demonstrate that Noxin ex-
pression is controlled by the cell cycle and suggests a possibility
that Noxin may interact with the cell cycle machinery.
Noxin can induce cell cycle arrest. To examine the possibil-
ity that Noxin may affect cell cycle progression, we transfected
NIH 3T3 cells with plasmids encoding FLAG-Noxin, p21/
WAF, p53, or p53dn. In addition, as controls, we used con-
structs coding for cyan fluorescent protein with a nuclear lo-
calization signal (CFP-nuc), yellow fluorescent protein fused to
actin (YFP-actin), or vector construct alone. We next labeled
cells with BrdU for 24 h and analyzed the cells in situ by
immunocytochemistry for BrdU and Noxin (or the other listed
proteins) (Fig. 6A and B). We then determined the fraction of
BrdU-positive cells among the cells that expressed the recom-
binant protein (transfected cells) and among the cells that did
not receive the transgene and did not express the recombinant
protein (untransfected cells). Comparison of these fractions
showed that Noxin was highly effective in suppressing DNA
synthesis in transfected cells (24% of the value for the untrans-
fected cells) (Fig. 6B). p21/WAF and p53 were also effective in
suppressing DNA synthesis in cells that received these genes
(39% and 68% of the values for the untransfected cells, re-
spectively), whereas CFP-nuc and YFP-actin (taken as con-
FIG. 5. noxin mRNA levels are regulated by the cell cycle. (A) NIH
3T3 cells, synchronized by serum starvation (DMEM with 0.5% serum for
24 h) were released from arrest by the addition of 10% serum (corre-
sponding to the zero hour time point). noxin mRNA expression was
analyzed using Q-PCR 0, 4, 14, or 20 h after the addition of serum. Asyn,
cells growing asynchronously; Noc, G2/M-arrested cells after treatment
with nocodazole for 20 h. The error bars indicate standard errors of the
mean. (B) In parallel, cell cycle distribution was determined by PI staining
and flow cytometry analysis; this confirmed that cells progress through the
cell cycle phases (0- to 20-h time points) or accumulate in G2/M (nocoda
zole). (C) Masses of Noxin protein determined by Western blotting.
(D) After transfection with pFLAG-noxin or pcDNA3 vector, cell
division was arrested with three different treatments (nocodazole,
aphidicolin, or a low concentration of serum). Recombinant protein
was detected on a Western blot using the anti-FLAG antibody. FLAG
epitope increases the electrophoretic mobility of the recombinant pro-
tein. (E) Cell cycle distribution of stress-exposed NIH 3T3 cells. The
cells were fixed with 70% ethanol for 16 h after stress treatment, and
the cell cycle distribution was determined by PI staining and flow
cytometry analysis. The segments of the bars depict the proportion of
cells in G1 (black), S (white), and G2/M (gray) phases of the cell cycle.
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trols) did not show any effect on DNA synthesis in transfected
cells (98% and 96%, respectively). To determine whether the
activity of p53 is required for the action of Noxin, we contrans-
fected Noxin with a dominant-inhibitory version of p53; this
did not affect the ability of Noxin to induce cell cycle arrest.
Similarly, Noxin was effective in suppressing DNA synthesis in
MEFs from p53-deficient mice. Together, these data show that
Noxin expression can induce cell cycle arrest and that this
action of Noxin does not require the activity of p53.
To determine the phase of the cell cycle affected by Noxin,
we transfected the NIH 3T3 cells with pFLAG-noxin- or GFP-
expressing recombinant plasmids and used flow cytometry fol-
lowing anti-FLAG staining and GFP fluorescence to compare
the DNA distribution in cells that expressed or did not express
the noxin transgene (Fig. 6C). Most of the pFLAG-noxin-
transfected cells had 2n DNA content, whereas untransfected
cells showed the usual distribution, with a fraction of cells
having a 4n DNA set. In control experiments, cells that re-
ceived or did not receive the GFP construct upon transfection
did not show any changes in the cell cycle distribution pattern.
This suggests that cells which express the transfected noxin
gene are arrested in G1 or early S phase.
Although our experiments with dominant-inhibitory p53 and
with p53/ MEFs (Fig. 6B) indicated that Noxin does not
require p53 to induce cell cycle arrest, we examined whether
Noxin expression can affect the cellular levels of p53. We
transfected cells with pFLAG-noxin- or GFP-expressing plas-
mids and determined the levels of p53 using immunocytochem-
istry and flow cytometry. p53 levels were increased only in the
cells that received the noxin gene but not in cells that did not
show expression of Noxin or in cells that received the GFP
gene (Fig. 7A and B). Thus, expression of Noxin elevates the
cellular levels of p53 and is itself induced in a p53-dependent
manner; however, Noxin does not require p53 to induce cell
cycle arrest.
Knockout of the noxin gene and the phenotype analysis of
noxin knockout mice. For further insights into the potential
function of Noxin, we decided to produce a targeted deletion
within the noxin gene. We targeted exon 6 of the gene, since a
large part of murine Noxin is encoded by this exon (Fig. 8A
and B). Replacement of these sequences with the neomycin
phosphotransferase gene inactivated the noxin gene so that
noxin mRNA could not be detected in the tissues of mice
carrying a homozygous deletion of the gene or in the embry-
onic fibroblasts derived from these knockout mice. Mice car-
rying one mutant noxin allele produced approximately half as
much noxin mRNA as the wild-type animals (Fig. 8C). noxin
heterozygotes produced homozygous mutant progeny at a nor-
mal Mendelian ratio, and the homozygous animals were born
with a normal ratio of male to female mice. Homozygous noxin
mutants were viable and fertile, developed without growth
retardation, and displayed no detectable abnormalities on
FIG. 6. Ectopic expression of Noxin induces G1 cell cycle arrest. (A) NIH 3T3 cells were transfected with pFLAG-noxin and cultured in
medium containing BrdU for 24 h. The cells were fixed and stained with anti-FLAG (red) and anti-BrdU (green) antibodies; Hoechst 33342 (blue)
was used for nuclear counterstaining. (B) The fractions of BrdU-labeled cells among the cell populations were determined for cells that express
or do not express the transfected gene. Similar experiments were performed using constructs for p21/WAF, p53, p53dn, CFP-Nuc, and YFP-actin.
The ratios of these fractions for transfected and untransfected cells are shown below the graph. Noxin action was also analyzed in p53-deficient
MEFs. The error bars indicate standard errors of the mean. (C) Cells transfected with pFLAG-noxin were stained with anti-FLAG antibody and
FITC-conjugated anti-mouse IgG antibody after permeabilization. Cell cycle distributions of untransfected and transfected cells were analyzed by
DAPI staining and flow cytometry.
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visual inspection and macroscopic analysis of the visceral or-
gans. One notable exception was the heart, which was larger in
the knockout animals (Table 1).
We further analyzed the structure of the testis, the major site
of Noxin expression. Testes of Noxin-deficient animals did not
show detectable differences in weight, diameter of seminifer-
ous tubules, or number of primary spermatocytes (Table 1).
However, we found a significant decrease in the number of
round spermatids in Noxin-deficient animals (Table 1).
Since the bone marrow and spleen are among the major sites
of Noxin expression, we examined whether hematopoiesis was
affected by disruption of the noxin gene We compared the
composition of blood and the content of hematopoietic pro-
genitors in the bone marrow and spleens of homozygous
knockout animals and their heterozygous and wild-type litter-
mates. We did not see significant differences in the blood cell
profile in peripheral blood, spleen, or bone marrow; in the
cellularity of the spleen or bone marrow; in the number of
CFC-8d and CFC-12d cells in the bone marrow; or in the
number of CFC-12d colonies in the spleen. We were able,
however, to detect differences in the number of CFC-8d cells in
the spleens of homozygous knockouts (12% increase; P 
0.05) and Sca1-positive cells in the bone marrow (a 45.5%
decrease; P  0.001). Thus, we could detect only a few signif-
icant differences between the wild-type and knockout mice in a
wide range of hematopoiesis-related parameters.
Since Noxin responds to various stress stimuli, we decided to
test the response of noxin mutant mice to lipopolysaccharide-
induced endotoxic shock. Lipopolysaccharide challenge in-
duces oxidative and nitrosative stress and, at high doses, results
in mortality. We compared the response of the wild-type
noxin/ mice with those of their littermates carrying a ho-
mozygous or a heterozygous deletion of the noxin gene and
could not find differences in mortality between the three ge-
notypes; it is possible that the threshold for detecting the
differences between the wild-type and noxin knockout mice was
not achieved.
Cell death is increased by noxin gene ablation or down
regulation. Since Noxin can induce cell cycle arrest and, in
addition, responds to various types of stress stimuli, including
NO, we compared the growth characteristics of MEFs isolated
from noxin/ animals or their wild-type (noxin/) litter-
mates. We either left cells untreated or exposed them to the
NO donor SNAP and then labeled the cells with BrdU; col-
FIG. 7. p53 upregulation in NIH 3T3 cells transfected with Noxin. (A) Cells transfected with pFLAG-noxin were stained with anti-FLAG and
anti-p53 primary antibodies and ALEXA Fluor 596- and 488-conjugated secondary antibodies, respectively. Cells expressing Noxin (red) showed
higher levels of p53 (green) than cells that did not express Noxin. (B) Cells transfected with pFLAG-noxin (top) and pEGFP (taken as a control;
bottom) were stained with anti-FLAG and anti-p53 primary antibodies and PE- and FITC-conjugated secondary antibodies. Then, Noxin-FLAG-
or EGFP-negative (left) and -positive (right) cells were analyzed for the amount of p53 protein by using flow cytometry.
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lected aliquots after 4, 16, and 22 h; and performed bivariate
DNA analysis using flow cytometry. Such analysis provides
detailed information on how cells progress through the cell
cycle, with a particular emphasis on the S phase. We could not
reveal noticeable differences in how the wild-type or mutant
cells traverse the S phase in the absence of NO (Fig. 9A). The
effect of SNAP on cells was dramatic, decreasing the fraction
of dividing cells by 95.5%; however, we did not detect any
differences between the responses of the wild-type versus the
mutant cells when analyzing either the fraction of cells in the S
phase or the kinetics of response to SNAP (Fig. 9A). Thus,
inactivation of the noxin gene does not noticeably affect the
rate of DNA synthesis or the response of cells to NO.
We noticed, however, that the fraction of sub-G1 cells was
higher in Noxin-deficient cells. At each time point analyzed,
this fraction was higher in noxin/ than in noxin/ MEFs
(13.8, 16.3, and 11.5 versus 9.7, 5.1, and 3.5%, respectively)
(Fig. 9B, fraction P6); incubation with SNAP did not notice-
ably affect this fraction in the noxin/ or noxin/ cells. Since
the sub-G1 fraction corresponds to dying cells that have lost
part of their DNA, these data suggest that lack of Noxin in-
creases the fraction of cells that undergo apoptosis. We further
tested this possibility by using alternative assays for apoptosis,
measuring annexin V PI cells (Fig. 9C and D) and TUNEL-
positive cells (Fig. 9E) among noxin/ and noxin/ cells. The
results of these assays showed that noxin/ MEFs had signif-
FIG. 8. Targeted inactivation of the noxin gene. (A) A part of exon 6 (the longest exon) in the noxin gene was replaced with a cassette
containing a neomycin resistance gene (B, BamHI; E, EcoRI; H, HindIII). (B) Genomic DNA of mutant mice was analyzed by PCR using specific
primer sets corresponding to the eliminated exon 6 (WT) and to the targeting cassette (KO). Wild-type or knockout mice carry only one type of
allele (WT or KO), while heterozygote mice have both alleles. (C) Total RNAs extracted from MEFs, adult bone marrow, and spleen were
analyzed by Q-PCR for the expression of noxin mRNA. Tissues from noxin/ (heterozygous) mice expressed approximately half as much noxin
mRNA as wild-type mice. noxin mRNA was not detected in tissues from noxin/ mice. The error bars indicate standard errors of the mean.
TABLE 1. Tissue weights and parameters in testes from wild-type and noxin/ micea
Genotype
Tissue wtb Values for parameters in testes
Heart Spleen Testis Seminiferous tubulediam (m) Spermatocytes
c Spermatidsc
Wild type 4.32 
 0.10 2.70 
 0.17 2.83 
 0.20 235.30 
 2.66 54.51 
 1.00 115.60 
 1.94
noxin/ 4.87 
 0.18* 2.88 
 0.28 2.48 
 0.11 230.49 
 2.69 52.18 
 1.06 107.65 
 1.98**
a Shown are values 
 standard errors. *, P  0.05; **, P  0.01.
b Milligram weight of organ per gram mouse body weight.
c Number of cells in a cross section of tubule.
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FIG. 9. MEFs isolated from noxin/ mice have normal growth and response to SNAP treatment but increased cell death. (A and B) MEFs from
wild-type (WT) and noxin/ mice were arrested with low-serum (0.1%) culture medium for 24 h and released by adding 10% serum. At the time of
release, BrdU was added to the culture medium and the cells were further incubated for 4, 16, or 22 h (as indicated). Cells were collected, stained with
PI, and analyzed by flow cytometry for BrdU-positive cells (x axis, PI; y axis, BrdU) (A) and for cell cycle distributions (x axis, PI; y axis, number of cells)
(B). (Populations: P3, G1; P4, S; P5, G2/M; P6, sub-G1). The growth of noxin
/ MEFs under normal conditions (A, g to i) and after the addition of SNAP
(A, j to l) were similar to that of wild-type MEFs (A, a to c and d to f). However, noxin/ MEFs contained a larger fraction of cells in sub-G1 phase.
(C to E) Wild-type and noxin/ MEFs were grown in normal culture medium or treated with the previous panel of stress stimuli (SNAP, cytokines, UV
irradiation, -irradiation, adriamycin, or hydrogen peroxide) for 16 h. Cells were collected and assayed for annexin V-positive cells (C and D) and
TUNEL-positive cells (E). Annexin V PI cells were quantified by flow cytometry (x axis, annexin V; y axis, PI). (Q1, annexin V PI; Q2, annexin V
PI; Q3, annexin V PI; Q4, annexin V PI). Examples are shown for untreated wild-type MEFs and Noxin-deficient MEFs (C). The graph shows
the percentage of annexin V PI cells (Q4) for each of the stress stimuli tested (D). The number of TUNEL-positive cells is expressed as a percentage
of the total cell population (E). The data shown in the bar graphs represent the means 
 standard errors.
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icantly larger numbers of apoptotic cells (140% by the annexin
assay and 285% by the TUNEL assay) than their wild-type
counterparts (Fig. 9D and E).
Furthermore, we applied the annexin assay for apoptosis to
noxin/ MEFs subjected to the panel of treatments described
above: SNAP, -irradiation, UV irradiation, adriamycin, hy-
drogen peroxide, and cytokines. For each type of stress, the
fraction of apoptotic cells was higher in Noxin-deficient MEFs
than in their wild-type counterparts (Fig. 9D). Together, these
three assays (DNA content measurement, TUNEL, and an-
nexin V/PI flow cytometry) indicate that lack of Noxin in-
creases the rate of programmed death in cells under normal
conditions or when challenged with stressful stimuli.
To further confirm this notion, we probed the role of Noxin
in normal cells by down regulating its expression using the
RNA interference approach. We generated six shRNA con-
structs, which corresponded to different regions of noxin
mRNA, and compared their efficiencies by coexpressing them
with recombinant noxin cDNA (Fig. 10A). The shRNA con-
struct that showed the highest efficiency in this assay (HPC)
was used to transfect NIH 3T3 cells treated with nocodazole
(to arrest the cells in the G2/M phase). The downregulation of
Noxin using this shRNA construct decreased the fraction of
cells in G2/M and increased the fraction of cells in the sub-G1
population: 5.7 
 0.4% in control cells versus 7.8 
 1.3% in
cells transfected with 1 g of HPC and 8.0 
 1.7% in cells
transfected with 2 g of HPC (Fig. 10B). Furthermore, cells
transfected with HPC often showed condensed nuclei charac-
teristic of apoptotic cells (Fig. 10C). Taken together, this series
of experiments indicated that Noxin acts as an anti-apoptotic
factor and that its absence increases cell death under normal
and stress conditions.
DISCUSSION
Here, we describe noxin, a new stress-induced gene, and a
mutant mouse line in which this gene is inactivated. noxin
mRNA and protein expression is controlled by the cell cycle; it
can also be activated by a wide range of stress stimuli. Noxin
plays an anti-apoptotic role, so that when the noxin gene is
inactivated or downregulated, cells exhibit significantly higher
levels of apoptosis than their counterparts with normal levels
of Noxin. This is evident under basal conditions and is main-
tained when cells are challenged by a range of dissimilar stress
stimuli. Thus, our data suggest that noxin is a general stress
response gene whose expression is related to the cell cycle and
whose product may be important to prevent cell death under a
wide range of conditions.
FIG. 10. noxin knockdown by shRNA increases the fraction of apoptotic cells after treatment with nocodazole. (A) Selection of shRNA
constructs. Six different shRNA constructs (HPA to HPF) were produced and examined for their abilities to suppress the expression of Noxin
protein. NIH 3T3 cells were cotransfected with constructs coding for Noxin shRNAs, FLAG-Noxin, and luciferase, and the lysates were examined
for luciferase expression. After normalization, protein samples were analyzed by Western blotting for the expression of FLAG-Noxin protein. The
HPC hairpin construct showed the strongest inhibition of Noxin expression, whereas HPF had no effect and was used as a control. (B) NIH 3T3
cells were transfected with 1 g (HPC) or 2 g (2 HPC) of the HPC shRNA construct, treated with nocodazole for 20 h, collected, stained with
PI, and analyzed for DNA content using flow cytometry. Nocodazole treatment resulted in accumulation of cells in the G2/M phases. Transfection
with HPC decreased the fraction of cells in G2/M while increasing the sub-G1 population. (C) Cells were cotransfected with the HPC or HPF
shRNA constructs, together with the YFP-actin construct, and stained with Hoechst stain. shRNA-transfected cells were identified by YFP
expression. HPC-transfected cells (yellow) showed condensed chromatin structures, corresponding to apoptotic cells (red arrowheads). The nuclei
of cells transfected with HPF and YFP-actin or with YFP-actin alone and the nuclei of nontransfected cells had normal shape (light-blue
arrowheads). Scale bars, 10 mm.
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We had initially identified noxin as an NO-inducible gene,
and indeed, it is activated by NO donors to a greater degree
than any other tested gene related to cell cycle progression, cell
death, or stress response (reference 13 and data not shown). Its
induction by SNAP is prevented by the deletion of the p53
gene, indicating that p53 is important for the expression of
noxin. noxin expression is induced both by chemical NO donors
and by in vivo stimuli that induce NO production, e.g., cyto-
kines; in the latter case, induction of noxin is dependent on the
activity of NOS and can be prevented by NOS inhibitors (ref-
erence 13 and unpublished results).
In addition to NO and cytokines, noxin is induced by a wide
range of stimuli: -irradiation, UV irradiation, adriamycin, and
hydrogen peroxide. These agents activate different immediate
targets but converge on a relatively small number of effectors,
which can slow down or halt the cell cycle, suppress cell death
pathways, and permit the repair process to proceed; alterna-
tively, these effectors may activate the cell death program to
eliminate defective cells. We propose that Noxin is a compo-
nent of the basic cell machinery that is activated by various
stressors, helps cells to withdraw from cycling, and prevents
cell death.
The idea that Noxin acts as a part of the stress response
system is strongly supported by our finding that a decrease or
loss of Noxin leads to increased cell death. This was evident in
three different types of assays (TUNEL, flow cytometry, and
annexin V/PI staining) and in all tested settings, whether using
cells from wild-type or noxin knockout animals or cells with
RNA interference-induced downregulation of noxin expression
(Fig. 9 and 10). The possible link to stress response is further
supported by the presence, in the Noxin molecule, of phosphor-
ylation sites for the ATM, DNA-PK, and Akt kinases, each of
which plays a critical role in the stress response (12, 16, 23, 26).
This link is also supported by the fact that for each stress
stimulus, induction of Noxin was dependent on p53 (Fig. 4D).
Furthermore, Noxin’s participation in the stress response is
compatible with the finding that it accumulates in the nucleus
in response to stress. At the same time, since it takes several
hours after the introduction of the stressor for the full induc-
tion of noxin, and since this induction is dependent on p53, it
is conceivable that Noxin does not participate in the first line of
defense against stress (e.g., compared with p53, whose rapid
involvement in the repair process is achieved via posttransla-
tional modification and increased stability of preexisting pro-
tein stores) (12, 23).
The possible role of Noxin as a component of the cellular
stress response system is further supported by its ability to
induce cell cycle arrest (Fig. 6). Ectopic expression of Noxin is
as, or more, effective than expression of the cell cycle inhibitors
p21/WAF and p53 in inducing cell cycle arrest. It forces the
cells to stall in G1/S, perhaps helping the cells to activate their
repair systems. Noxin was effective in inducing cell cycle arrest
even in the absence of p53 activity (in p53/ MEFs or when
cotransfected with a dominant-negative p53 construct), indi-
cating that it acts downstream or independently of p53. Note,
however, that Noxin induction is dependent on p53 and that
Noxin can, in turn, induce p53 levels. This suggests a model in
which stress stimuli, in a p53-dependent manner, induce ex-
pression of Noxin, which then induces cell cycle arrest and
elevates the levels of p53; the latter, however, is not required
for the antiproliferative action of Noxin.
In addition to its ability to control cell cycle progression,
Noxin is itself controlled by the cell cycle: the amount of noxin
mRNA is very small in resting cells but increases almost 50-
fold as the cells progress through S phase. In addition, its levels
are decreased when cells are arrested by serum deprivation.
Furthermore, noxin mRNA is mainly expressed in tissues that
contain actively proliferating cell populations, such as bone
marrow, spleen, and testis; also, it is expressed at much higher
levels in actively dividing NIH 3T3 cells than in slowly dividing
MEFs. The presence of Noxin may be required in dividing cells
to help protect them from stress and damage.
Although we clearly saw the consequences of the loss of the
noxin gene in cultured cells, we were able to see only small
changes in knockout animals (e.g., heart size, the level of
Sca1 cells, and the number of round spermatids). So far, we
have been unable to reveal the effect of deleting the gene on
the animals’ response to stress, e.g., to endotoxic shock; per-
haps the loss of the noxin gene has a more subtle effect and
other stress survival paradigms are required to reveal its con-
tribution. Noxin also seems to be dispensable for the mainte-
nance of the tissues and organs where it is expressed at high
levels (testis, spleen, and bone marrow). It may require a
focused challenge to these organs to reveal the role of Noxin as
a stress response agent. Intriguingly, primary spermatocytes
are more resistant to NO-induced apoptosis than other types
of cells involved in spermatogenesis, e.g., spermatids (7). This
is compatible with our observations that Noxin is selectively
expressed in primary spermatocytes and that in the knockout
animals, the number of TUNEL-positive cells in the seminif-
erous tubules is increased (data not shown) and is accompa-
nied by a decrease in the number of spermatids. These obser-
vations suggest that Noxin may contribute to the protection of
the germ line cells from nitrosative stress or other types of
insults.
In conclusion, we cloned a novel gene that is controlled by
the cell cycle; is activated in response to nitrosative, oxidative,
and other types of stresses; is able to induce cell cycle arrest
when ectopically expressed; and acts to counteract apoptotic
stimuli, so that its loss results in an increased level of cell death.
Our results suggest that Noxin may be a part of the machinery
that protects cells during stress by helping them to withdraw
from the cell cycle and repair the damage. Noxin may thus
directly participate in the repair process and may even be a
part of the protein complexes that restore the integrity of the
genome after insult and stress.
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